Richard J. Sciotti

2.6k total citations
48 papers, 1.6k citations indexed

About

Richard J. Sciotti is a scholar working on Public Health, Environmental and Occupational Health, Organic Chemistry and Epidemiology. According to data from OpenAlex, Richard J. Sciotti has authored 48 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Public Health, Environmental and Occupational Health, 22 papers in Organic Chemistry and 18 papers in Epidemiology. Recurrent topics in Richard J. Sciotti's work include Research on Leishmaniasis Studies (18 papers), Trypanosoma species research and implications (17 papers) and Synthesis and Biological Evaluation (10 papers). Richard J. Sciotti is often cited by papers focused on Research on Leishmaniasis Studies (18 papers), Trypanosoma species research and implications (17 papers) and Synthesis and Biological Evaluation (10 papers). Richard J. Sciotti collaborates with scholars based in United States, Serbia and United Kingdom. Richard J. Sciotti's co-authors include William Roush, Sandra Koterski, C. J. Carlson, Cristina M. Rondinone, Susan E. Leed, Michael P. Pollastri, Stevan W. Djurić, Patricia Lee, Diana Caridha and Ana Rodrı́guez and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Diabetes.

In The Last Decade

Richard J. Sciotti

47 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard J. Sciotti United States 25 623 543 537 347 120 48 1.6k
Robert T. Jacobs United States 27 625 1.0× 413 0.8× 755 1.4× 515 1.5× 208 1.7× 43 1.9k
Michael P. Pollastri United States 26 653 1.0× 587 1.1× 666 1.2× 651 1.9× 80 0.7× 69 1.8k
Vikash Kumar India 23 434 0.7× 333 0.6× 789 1.5× 232 0.7× 144 1.2× 86 1.9k
Yew Mun Lee Singapore 20 237 0.4× 362 0.7× 825 1.5× 235 0.7× 197 1.6× 33 1.7k
S.K. Puri India 31 1.5k 2.5× 878 1.6× 720 1.3× 180 0.5× 171 1.4× 95 2.9k
Francisco Hernández‐Luis Mexico 23 962 1.5× 237 0.4× 337 0.6× 203 0.6× 95 0.8× 53 1.6k
M.S. Alphey United Kingdom 22 270 0.4× 240 0.4× 1.0k 1.9× 264 0.8× 61 0.5× 38 1.4k
Edeildo Ferreira da Silva‐Júnior Brazil 23 391 0.6× 343 0.6× 451 0.8× 198 0.6× 111 0.9× 93 1.3k
Yingke He Singapore 13 143 0.2× 367 0.7× 450 0.8× 178 0.5× 138 1.1× 23 1.3k
Jin‐Cherng Lien Taiwan 27 529 0.8× 174 0.3× 959 1.8× 123 0.4× 173 1.4× 113 2.1k

Countries citing papers authored by Richard J. Sciotti

Since Specialization
Citations

This map shows the geographic impact of Richard J. Sciotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Sciotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Sciotti more than expected).

Fields of papers citing papers by Richard J. Sciotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Sciotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Sciotti. The network helps show where Richard J. Sciotti may publish in the future.

Co-authorship network of co-authors of Richard J. Sciotti

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Sciotti. A scholar is included among the top collaborators of Richard J. Sciotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Sciotti. Richard J. Sciotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buskes, Melissa J., Hitesh B. Jalani, Seema Bag, et al.. (2020). Structure–Bioactivity Relationships of Lapatinib Derived Analogs against Schistosoma mansoni. ACS Medicinal Chemistry Letters. 11(3). 258–265. 2 indexed citations
2.
Caridha, Diana, Mark Hickman, Lisa Xie, et al.. (2019). Updating the modified Thompson test by using whole-body bioluminescence imaging to replace traditional efficacy testing in experimental models of murine malaria. Malaria Journal. 18(1). 38–38. 6 indexed citations
3.
Bocxlaer, Katrien Van, Diana Caridha, Brian A. Vesely, et al.. (2019). Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis. International Journal for Parasitology Drugs and Drug Resistance. 11. 129–138. 55 indexed citations
4.
Caridha, Diana, Brian A. Vesely, Katrien Van Bocxlaer, et al.. (2019). Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis. International Journal for Parasitology Drugs and Drug Resistance. 11. 106–117. 63 indexed citations
5.
Ferrins, Lori, Amrita Sharma, Jessey Erath, et al.. (2018). Anilinoquinoline based inhibitors of trypanosomatid proliferation. PLoS neglected tropical diseases. 12(11). e0006834–e0006834. 8 indexed citations
6.
Woodring, Jennifer L., Jessey Erath, Sofie Tanghe, et al.. (2017). Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation. European Journal of Medicinal Chemistry. 141. 446–459. 17 indexed citations
7.
Djurković–Djaković, Olgica, et al.. (2017). Antimalarials with Benzothiophene Moieties as Aminoquinoline Partners. Molecules. 22(3). 343–343. 18 indexed citations
8.
Leed, Susan E., Norma Roncal, Jacob D. Johnson, et al.. (2015). Antileishmanial Activity of Compounds Derived from the Medicines for Malaria Venture Open Access Box Against Intracellular Leishmania major Amastigotes. American Journal of Tropical Medicine and Hygiene. 94(2). 340–347. 26 indexed citations
9.
Opsenica, Igor, Tatjana Ž. Verbić, Richard J. Sciotti, et al.. (2015). Investigation into novel thiophene- and furan-based 4-amino-7-chloroquinolines afforded antimalarials that cure mice. Bioorganic & Medicinal Chemistry. 23(9). 2176–2186. 21 indexed citations
10.
Marcsisin, Sean R., Jason Sousa, Gregory A. Reichard, et al.. (2014). Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds. Malaria Journal. 13(1). 2–2. 67 indexed citations
11.
Sciotti, Richard J., et al.. (2014). The synthesis, antimalarial activity and CoMFA analysis of novel aminoalkylated quercetin analogs. Bioorganic & Medicinal Chemistry Letters. 25(2). 327–332. 38 indexed citations
12.
Sharlow, Elizabeth R., Stephanie Leimgruber, Ana Amélia Moreira Lira, et al.. (2013). Auranofin Is an Apoptosis-Simulating Agent within Vitroandin VivoAnti-leishmanial Activity. ACS Chemical Biology. 9(3). 663–672. 52 indexed citations
13.
Marcsisin, Sean R., Xiannu Jin, Jason Sousa, et al.. (2013). CYP450 phenotyping and metabolite identification of quinine by accurate mass UPLC-MS analysis: a possible metabolic link to blackwater fever. Malaria Journal. 12(1). 214–214. 17 indexed citations
14.
Grögl, Max, Mark Hickman, William Ellis, et al.. (2013). Drug Discovery Algorithm for Cutaneous Leishmaniasis. American Journal of Tropical Medicine and Hygiene. 88(2). 216–221. 28 indexed citations
15.
Opsenica, Igor, Laura Gomba, Jonathan E. Nuss, et al.. (2013). 4-Amino-7-chloroquinolines: Probing Ligand Efficiency Provides Botulinum Neurotoxin Serotype A Light Chain Inhibitors with Significant Antiprotozoal Activity. Journal of Medicinal Chemistry. 56(14). 5860–5871. 23 indexed citations
16.
Starr, Jeremy T., Richard J. Sciotti, Debra Hanna, et al.. (2009). 5-(2-Pyrimidinyl)-imidazo[1,2-a]pyridines are antibacterial agents targeting the ATPase domains of DNA gyrase and topoisomerase IV. Bioorganic & Medicinal Chemistry Letters. 19(18). 5302–5306. 58 indexed citations
17.
Rose, Kelly, et al.. (2009). Structure-Activity Relationship (SAR): Effort Towards Blocking NGlucuronidation of Indazoles (PF-03376056) By Human UGT1A Enzymes. Drug Metabolism Letters. 3(1). 28–34. 4 indexed citations
18.
Somwar, Romel, Sandra Koterski, Gary Sweeney, et al.. (2002). A Dominant-negative p38 MAPK Mutant and Novel Selective Inhibitors of p38 MAPK Reduce Insulin-stimulated Glucose Uptake in 3T3-L1 Adipocytes without Affecting GLUT4 Translocation. Journal of Biological Chemistry. 277(52). 50386–50395. 112 indexed citations
19.
Sciotti, Richard J., Marina Pliushchev, Paul E. Wiedeman, et al.. (2002). The synthesis and biological evaluation of a novel series of antimicrobials of the oxazolidinone class. Bioorganic & Medicinal Chemistry Letters. 12(16). 2121–2123. 49 indexed citations
20.
Warrior, Usha, X. Grace Chiou, Michael P. Sheets, et al.. (1999). Development of a p38 Kinase Binding Assay for High Throughput Screening. SLAS DISCOVERY. 4(3). 129–135. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026